Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Aripiprazole in Overweight Patients With Schizophrenia
NCT00222833Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Oct 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia, schizoaffective disorder, sponsored by University of Pittsburgh. Started Oct 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00222833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222833.